Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Links relacionados
Similares en SciELO
Compartir
Revista Cubana de Angiología y Cirugía Vascular
versión On-line ISSN 1682-0037
Resumen
IGLESIAS CARBONELL, Seila. Characterization of patients with diabetic foot in “Pedro Borrás Astorga” Polyclinic, Pinar del Río province. Rev Cubana Angiol Cir Vasc [online]. 2021, vol.22, n.2, e306. Epub 01-Jul-2021. ISSN 1682-0037.
Introduction:
Diabetic foot is one of the most common chronic complications of diabetes mellitus and represents a risk of disability among the patients who suffer it.
Objective:
Characterize the behaviour of the diabetic foot ulcers in patients from “Pedro Borrás Astorga” Polyclinic, in Pinar del Río province.
Methods:
A descriptive, observational and retrospective study was carried out in 44 patients in the ages from 19 to 85 years , whom were attended during the period June-December, 2019 due to diabetic foot wounds. There were applied some questionnaries and it was analized the information of the personal clinical records. The assessed variables were: sex, age, evolution time of the disease, place of residence, risk factors, clinical calssification of the wounds and evolution of the treatment with Heberprot-P®..
Results:
Diabetic foot had more prevalence in women from 40 years old and it usually affects patients who live in urban areas. The most common risk factors were: obesity, alcoholism, smoking habit, arterial hypertension, and arterial insufficiency. The treatment with Heberprot-P showed a positive evolution in patients with Wagner 1 and 2 type of wounds.
Conclusions:
Th estudies conducted on the diabetic foot wounds show its prevalence from 40 years old, with an increasing trend as the age is higher. In the same way, the female sex has a trend to suffer with more frequency this complication. The treatment with Heberprot-P® in Wagner 1 and 2 type of wounds has a positive evolution, and reduces the risks of amputation.
Palabras clave : Diabetic foot; diabetes mellitus; Heberprot-P®.